A Study (Study 2) to Evaluate the Safety and Efficacy of FMX103 1.5% Topical Minocycline Foam in the Treatment of Facial Papulopustular Rosacea
Condition: Facial Papulopustular Rosacea Interventions: Drug: FMX103 minocycline foam 1.5%; Drug: Vehicle foam Sponsors: Foamix Ltd.; Premier Research Group plc Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 29, 2020 Category: Research Source Type: clinical trials